Cargando…

Combined Low Dose of Ketamine and Social Isolation: A Possible Model of Induced Chronic Schizophrenia-Like Symptoms

INTRODUCTION: Identifying a feasible model of chronic schizophrenia would be valuable for studying the possible underlying mechanism and to investigate emerging treatments. Our hypothesis starts from the observation that combining ketamine with isolation could result in long-lasting neuro-psychologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khalifa, D., Rashed, L., Shamseldeen, A., Stephan, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566060/ http://dx.doi.org/10.1192/j.eurpsy.2022.505

Ejemplares similares

Combined Low Dose of Ketamine and Social Isolation: A Possible Model of Induced Chronic Schizophrenia-Like Symptoms in Male Albino Rats
por: Estaphan, Suzanne, et al.
Publicado: (2021)

PT611. The combination of sub-effective doses of agmatine and ketamine reduces obsessive-compulsive-like behavior of mice in marble burying test
por: Keles, Rumeysa, et al.
Publicado: (2016)

Low Doses of Ketamine and Melatonin in Combination Produce Additive Antidepressant-like Effects in Mice
por: Estrada-Reyes, Rosa, et al.
Publicado: (2021)

PM363. The effect of Ketamine: Gunn rat as a Schizophrenia animal model
por: Hayashida, Maiko, et al.
Publicado: (2016)

F197. PROMOTING MYELIN REPAIR RESCUES MICE FROM SCHIZOPHRENIA-LIKE BEHAVIOR INDUCED BY SOCIAL ISOLATION
por: Xiao, Lan
Publicado: (2018)

25.4 PROMOTING MYELIN REPAIR RESCUES MICE FROM SCHIZOPHRENIA-LIKE BEHAVIOR INDUCED BY SOCIAL ISOLATION
por: Xiao, Lan
Publicado: (2018)

3.3 DISTURBANCES IN NEURAL OSCILLATIONS, GLUTAMATE, AND GABA: EFFECTS OF KETAMINE AND COMPARISON TO SCHIZOPHRENIA
por: Kegeles, Lawrence, et al.
Publicado: (2018)

Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans
por: Driesen, Naomi R., et al.
Publicado: (2013)

Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine
por: Curic, Stjepan, et al.
Publicado: (2019)

Low-dose ketamine in the prehospital setting
por: Yuhalogarasan, Alvin, et al.
Publicado: (2022)

S68. SYMPTOMS, NEUROCOGNITION, SOCIAL COGNITION AND METACOGNITION IN SCHIZOPHRENIA: A NETWORK ANALYSIS
por: Hasson-Ohayon, Ilanit, et al.
Publicado: (2018)

T202. HUMOR-SKILLS TRAINING IN PATIENTS WITH SCHIZOPHRENIA: EFFECTS ON SYMPTOMS AND SOCIAL FUNCTIONING
por: Falkenberg, Irina, et al.
Publicado: (2018)

PM521. Relationship between Negative Symptoms and Social Cognition in Patient with Schizophrenia
por: Hyun, Jiewon, et al.
Publicado: (2016)

A possible explanation for resistance in schizophrenia
por: Emna, B., et al.
Publicado: (2022)

Is ketamine and lamotrigine interactions responsible for the sub-therapeutic effect of ketamine?
por: Adnan, M., et al.
Publicado: (2021)

Comment on: “Low-Dose Ketamine for Outpatient Hysteroscopy.”
por: Raghuraman, M.S.
Publicado: (2021)

The effect of combined treatment with morphine sulphate and low-dose ketamine in a prehospital setting
por: Johansson, Patric, et al.
Publicado: (2009)

Predictive biomarkers for negative symptoms in schizophrenia
por: Cakici, N., et al.
Publicado: (2021)

Marker of schizophrenia with enduring negative symptoms
por: Dmitrieva, E., et al.
Publicado: (2022)

Narrative Review: Low-Dose Ketamine for Pain Management
por: Riccardi, Alessandro, et al.
Publicado: (2023)

BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling “Negative-Like” Symptoms of Schizophrenia
por: Zemba Cilic, Andrea, et al.
Publicado: (2022)

S42. KETAMINE DYSREGULATES TASK-RELATED NEURAL OSCILLATIONS IN THALAMO-CORTICAL CIRCUITS: IMPLICATIONS FOR PATHOPHYSIOLOGICAL THEORIES OF VISUAL-PERCEPTUAL DEFICITS IN SCHIZOPHRENIA
por: Grent-’t-Jong, Tineke, et al.
Publicado: (2018)

Efficacy and Safety of Low Dose Ketamine and Midazolam Combination for Diagnostic Upper Gastrointestinal Endoscopy in Children
por: Akbulut, Ulas Emre, et al.
Publicado: (2015)

S115. SYMPTOM DOMAINS IN SCHIZOPHRENIA AND GENE POLYMORPHISMS
por: Peitl, Vjekoslav, et al.
Publicado: (2018)

Metacognition, symptoms and general functioning in patients with schizophrenia
por: Daoud, M., et al.
Publicado: (2021)

Assessment of obsessive and compulsive symptoms in patients with schizophrenia
por: Ajmi, S., et al.
Publicado: (2022)

Assessment of depressive symptoms in hospitalized patients with schizophrenia
por: Abdelkefi, M., et al.
Publicado: (2022)

Late-onset schizophrenia patients with social phobia receive higher doses of antipsychotics compared patients without social phobia: results of an observational study
por: Pochueva, V., et al.
Publicado: (2022)

Safety and Tolerability of Intramuscular and Sublingual Ketamine for Psychiatric Treatment in the Roots to Thrive Ketamine Assisted Therapy Program
por: Tsang, V. W. L., et al.
Publicado: (2023)

Efficacy of Adding Low-Dose Ketamine to Dexmedetomidine Versus Low-Dose Ketamine and Propofol for Conscious Sedation in Patients Undergoing Awake Fiber-optic Intubation
por: El Sharkawy, Reem Abdelraouf
Publicado: (2019)

Prodromal stage and clinical features of late-onset schizophrenia and schizophrenia-like psychosis
por: Pochueva, V., et al.
Publicado: (2023)

Combination of clozapine, cariprazine and fluoxetine in treatment-resistant schizophrenia patient with prominent negative symptoms: A Case report
por: Everte, I., et al.
Publicado: (2022)

Ketamine and Electroconvulsive Therapy: Better Together?
por: Fraga, A., et al.
Publicado: (2022)

The antidepressant properties of ketamine (literature review)
por: Chamsi, F. Z., et al.
Publicado: (2023)

Race Differences in COVID-19 Stress and Social Isolation: Implications for Depressive Symptoms
por: Birditt, Kira, et al.
Publicado: (2021)

T47. IS THERE A DIURNAL VARIATION IN PSYCHIATRIC SYMPTOMS IN SCHIZOPHRENIA?
por: Daniel, David, et al.
Publicado: (2018)

Negative and Cognitive Symptoms of Schizophrenia: Are there Adequate Pharmacological Treatments?
por: Vasiliu, O.
Publicado: (2022)

Overlapping of clinical symptoms between schizophrenia and bipolar disorder
por: Tahirovic, A., et al.
Publicado: (2022)

Clinical Indicators of Symptom Dimensions and Cognitive Ability in Schizophrenia
por: Farakish, L., et al.
Publicado: (2022)

Negative symptoms and associated factors in older people with schizophrenia
por: Karoui, M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_grta6bhln0f5kb125ghpbg90dr